Doseology Sciences (XCNQ:MOOD) EV-to-EBIT : -0.38 (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Doseology Sciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Doseology Sciences's Enterprise Value is C$0.52 Mil. Doseology Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.35 Mil. Therefore, Doseology Sciences's EV-to-EBIT for today is -0.38.

The historical rank and industry rank for Doseology Sciences's EV-to-EBIT or its related term are showing as below:

XCNQ:MOOD' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.13 Med: -0.31 Max: 0.48
Current: -0.38

During the past 4 years, the highest EV-to-EBIT of Doseology Sciences was 0.48. The lowest was -1.13. And the median was -0.31.

XCNQ:MOOD's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs XCNQ:MOOD: -0.38

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Doseology Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was C$-0.45 Mil. Doseology Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.35 Mil. Doseology Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 299.83%.

Doseology Sciences EV-to-EBIT Historical Data

The historical data trend for Doseology Sciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences EV-to-EBIT Chart

Doseology Sciences Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

-0.83

0.01

Doseology Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial										-0.25	-0.61	0.01	-0.57	0.33

Competitive Comparison of Doseology Sciences's EV-to-EBIT

For the Biotechnology subindustry, Doseology Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Doseology Sciences's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's EV-to-EBIT falls into.

Doseology Sciences EV-to-EBIT Calculation

Doseology Sciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.517	/	-1.352
	=	-0.38

Doseology Sciences's current Enterprise Value is C$0.52 Mil.
Doseology Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.35 Mil.

Doseology Sciences (XCNQ:MOOD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Doseology Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-1.352	/	-0.450922
	=	299.83 %

Doseology Sciences's Enterprise Value for the quarter that ended in Dec. 2023 was C$-0.45 Mil.
Doseology Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.35 Mil.

Doseology Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Doseology Sciences (XCNQ:MOOD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (XCNQ:MOOD) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

DOSEF:USA

Address

116 - 5100 Anderson Way, Unit 197, Vernon, BC, CAN, V1T 0C4

Website

https://www.doseology.com

Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.

Doseology Sciences (XCNQ:MOOD) Headlines

No Headlines